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Abstract
Background: Studies have shown that the excessive fructose intake may induce adverse metabolic effects. There is
no direct evidence from epidemiological studies to clarify the association between usual amounts of fructose
intake and the metabolic syndrome.
Objective: The aim this study was to determine the association of fructose intake and prevalence of metabolic
syndrome (MetS) and its components in Tehranian adults.
Methods: This cross-sectional population based study was conducted on 2537 subjects (45% men) aged 19-70 y,
participants of the Tehran Lipid and Glucose Study (2006-2008). Dietary data were collected using a validated 168
item semi-quantitative food frequency questionnaire. Dietary fructose intake was calculated by sum of natural
fructose (NF) in fruits and vegetables and added fructose (AF) in commercial foods. MetS was defined according to
the modified NCEP ATP III for Iranian adults.
Results: The mean ages of men and women were 40.5 ± 13.6 and 38.6 ± 12.8 years, respectively. Mean total
dietary fructose intakes were 46.5 ± 24.5 (NF: 19.6 ± 10.7 and AF: 26.9 ± 13.9) and 37.3 ± 24.2 g/d (NF: 18.6 ± 10.5
and AF: 18.7 ± 13.6) in men and women, respectively. Compared with those in the lowest quartile of fructose
intakes, men and women in the highest quartile, respectively, had 33% (95% CI, 1.15-1.47) and 20% (95% CI, 1.09-
1.27) higher risk of the metabolic syndrome; 39% (CI, 1.16-1.63) and 20% (CI, 1.07-1.27) higher risk of abdominal
obesity; 11% (CI, 1.02-1.17) and 9% (CI, 1.02-1.14) higher risk of hypertension; and 9% (CI, 1-1.15) and 9% (1.04-1.12)
higher risk of impaired fasting glucose.
Conclusion: Higher consumption of dietary fructose may have adverse metabolic effects.
Keywords: Dietary fructose, Metabolic syndrome, Tehran Lipid and Glucose Study
Introduction
Fructose is the sweetest tasting carbohydrate, found in
many fruits and vegetables. In the past, dietary intake of
fructose was used to be 16-20 grams per day, mainly from
fresh fruits and vegetables. But in the last three decades,
increased consumption of industrialized foods such as soft
drinks, fruit juices, bakery products, canned fruits, jams,
jellies and cookies, containing added sugars (sucrose, high
fructose corn syrup, honey, molasses, and other syrups)
has resulted in a significant increase in fructose intakes of
85-100 grams per day [1,2]. Recent data suggest parallel
increasing trends in fructose intake and the increase in
obesity and type 2 diabetes in the last 35 years [3,4].
Reports confirmed by animal and human clinical studies,
indicating that the excessive fructose intakes induce
adverse metabolic effects [5-10]; however there is no direct
evidence from epidemiological studies to clarify the asso-
ciation between current amounts of dietary fructose intake
and the metabolic syndrome components. Metabolic syn-
drome (MetS), a worldwide epidemic health problem, is
characterized by central obesity, hypertension, insulin
resistance, and lipid profiles abnormalities [11]. The preva-
lence of MetS in Iranian adults is reported to be one of
the highest worldwide, with a rate of 33.7% [12,13].
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Considering the lack of data on dietary fructose intake in
Iranian adults, the aim of this cross sectional study was to
assess dietary intakes of fructose and to investigate the
association between fructose intake and prevalence of
MetS risk factors, in a sample selected from the Tehran
Lipid and Glucose Study.
Methods
Participants
Data were obtained from subjects of the Tehran Lipid and
Glucose Study (TLGS) between 2006-2008. Details of the
Tehran Lipid and Glucose Study have been reported else-
where [14,15]. Briefly, TLGS is a community-based pro-
spective study conducted to investigate and prevent non-
communicable diseases, in a representative sample of resi-
dents, aged ≥ 3y, from district 13 of Tehran, the capital of
Iran. The first phase of the TLGS began in March 1999
and data collection, at three-year intervals, is ongoing [15].
From 12 523 subjects, aged ≥ 3 years, in 2006-2008, 4920
were randomly selected for dietary assessment, based on
age and sex categorization, and 3462 (70 percent) com-
pleted the dietary assessment [16]. Of these, 2799 men
and women aged 19-70 y, were recruited for this study.
Subjects with under- or over reporting of dietary intakes
(less than 800 kcal/d or more than 4200 kcal/d, respec-
tively) were excluded. Finally, the data of 2537 adults
(1141men and 1396 women) were analyzed.
Dietary intake assessment and fructose intake estimation
Dietary data were collected by using a validated semi-
quantitative food frequency questionnaire (FFQ) with 168
food items, based on consumption frequency for each
food item during the past year, on a daily, weekly or
monthly basis [17]. Since the Iranian Food composition
Table (FCT), with limited data on nutrient content of raw
foods and beverages, is incomplete, the U.S Department of
Agriculture (USDA) FCT was used to calculate energy and
nutrient intakes [18]. However the Iranian FCT was used
for some national foods that are not listed in the USDA
FCT [19]. Dietary intakes of naturally-occurring fructose
from fructose-containing food such as fruits, vegetables,
honey, etc, were defined as “natural fructose (NF)” and
were calculated using the USDA FCT. Dietary simple car-
bohydrates was defined as total intakes of disaccharides
(sucrose, galactose, lactose), monosaccharides (fructose,
glucose, maltose), and the content of added sugar in
industrialized foods. Intakes of fructose from industrialized
foods and beverages containing beet or cane sugar/
molasses, corn sweeteners and invert syrup were defined
as “added fructose (AF)”. Since there are no databases for
added sugar content of Iranian food products, the USDA
database for added sugar was used to identify the added
sugar contents of food items [20,21]. The most commonly
added sugar in Iranian food products is sucrose, while
other sweeteners such as corn syrup are not commonly
employed. Hence 50% of added sugar in food products
was considered as fructose. Eventually the intakes of total
fructose were calculated by summing up natural fructose
and added fructose consumed.
Clinical and biological measurements
Trained interviewers collected information using a pre-
tested questionnaire [14]. Weight was measured to the
nearest 100 g with digital scales, while the subjects were
minimally clothed without shoes. Height was measured to
the nearest 0.5 cm, in a standing position without shoes,
using a tape meter. Waist circumference was measured to
the nearest 0.1 cm, at the umbilical level and that of the
hip, at the maximum level, over light clothing, using an
unstretched tape meter, without any pressure to the body.
Body mass index was calculated as weight (kg) divided by
square of the height (m2). For blood pressure measure-
ments, after a 15-minute rest in the sitting position, two
measurements of blood pressure were taken, on the right
arm, using a standardized mercury sphygmomanometer;
the mean of the two measurements was considered as the
participant’s blood pressure. Fasting blood samples were
taken after 12-14 h, from all study participants. Fasting
plasma glucose was measured by the enzymatic colori-
metric method using glucose oxidase. Triglyceride levels
were measured by enzymatic colorimetric analysis with
glycerol phosphate oxidase. High-density lipoprotein cho-
lesterol (HDL-C) was measured after precipitation of the
apolipoprotein B containing lipoproteins with phospho-
tungistic acid. Analyses were performed using Pars
Azmon kits (Pars Azmon Inc., Tehran, Iran) and a Selectra
2 auto-analyzer (Vital Scientific, Spankeren, Netherlands).
Inter- and intra assay coefficient of variation of all assays
were < 5% [14].
Metabolic syndrome definition
Metabolic syndrome was defined according to the diagnos-
tic criteria proposed by NCEP ATP III, and new cutoff
points of waist circumference for Iranian adults; it was
characterized as having at least 3 of the metabolic abnorm-
alities: 1) Fasting plasma glucose ≥ 100 mg/dL (5.6 mmol/
L) or drug treatment of hyperglycemia, 2) serum triglycer-
ides ≥ 150 mg/dL (1.69 mmol/L) or drug treatment, 3)
serum HDL-cholesterol < 40 mg/dL (1.04 mmol/L) for
men, and < 50 mg/dL (1.29 mmol/L) for women or drug
treatment, 4) blood pressure ≥ 130/85 mmHg or drug
treatment for hypertension, and 5) waist circumference
≥ 95 cm for both sexes [22,23].
Statistical analysis
Statistical analysis was performed using SPSS (Version
16.0; Chicago, IL), with P values < 0.05 being considered
significant. Dietary intakes of fructose were adjusted for
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energy intakes: [(fructose intake (g/d) × 1000/energy
intake (kcal/d)]. Total dietary fructose was assigned as
quartile intakes for men and women, based on their
25th- 50th- 75th percentile values. Total dietary fructose
intakes (g/1000 kcal/d) in the 1st, 2 nd, 3rd and 4th quar-
tiles were ≤ 13.3, 13.4-17.5, 17.6-23.7, and > 23.7 in
men, and ≤ 10.3, 10.4-15.2, 15.3-20.8, and > 20.8 in
women. Differences in general characteristics of partici-
pants across quartiles of fructose intakes were compared
using one-way analysis of variance or the Chi-square
test. Age adjusted means for dietary intakes across quar-
tiles of fructose, were determined by using the general
linear model. Means of metabolic syndrome features
were compared across quartiles of fructose intake by
using general linear model with adjustment for age
(categorized, 19-30, 31-40, 41-50, 51-60, 61-70; groups 1
to 5), physical activity (continuous), energy intake (kcal/
d), and smoking (yes or no). The associations between
total dietary fructose and metabolic syndrome risk fac-
tors, as continuous variables, were determined by using
multivariate linear regression model with adjustment for
age (categorized), BMI (except for waist circumference
and MetS), physical activity (in MET-h/wk), smoking
(yes or no), energy intake (kcal/d), percentage of energy
from fat, carbohydrate and simple carbohydrate (except
fructose), total fiber intake (g/d), and also adjustment
for current estrogen use (yes or no) and menopausal
status (yes or no) in women. Also, the odds ratio of
MetS and its component in each quartiles of total fruc-
tose intake was determined by using multivariable logis-
tic regression model with adjustment for the above-
mentioned confounders. Since, the odds ratio, which
was estimated from logistic regression models in cross
sectional studies, is not a valid estimation in binary out-
come variables with a high prevalence (> 10%), the
adjusted odds ratios were corrected by the formula sug-
gested by Zhang and Yu, for better estimation of the
association [24,25]. To assess the overall trends of odds
ratios across increasing quartiles of total fructose intake,
the median fructose intake of each quartile was used as
a continuous variable in logistic regression models [26].
Results
In this study, 45% and 55% of participants were men and
women, with mean ages of 40.5 ± 13.6 and 38.6 ± 12.8
years, respectively. Mean dietary intakes of total fructose
were 46.5 ± 24.5 g/d (NF: 19.5 ± 10.7 and AF: 26.9 ± 13.9)
in men and 37.3 ± 24.2 g/d (NF: 18.6 ± 10.5 and AF: 19 ±
13.7) in women; these intakes were approximately 8 and 7
percent of the total energy intakes, in men and women
respectively. Characteristics of the study participants
across quartiles of total fructose intakes are presented in
Table 1. Participants in the highest quartile of fructose
intakes were significantly older as compared with
participants in the lowest quartile. Also, means of body
mass index and the prevalence of metabolic syndrome
were significantly increased across quartiles of dietary
intakes of fructose in both sexes. No significant difference
in smoking status and physical activity was observed
across quartiles of fructose intakes. Age-adjusted means
for dietary intakes across categories of dietary fructose are
shown in Table 2. Dietary intakes of carbohydrate (% of
kcal), total sugar (% of kcal), natural and added fructose
(% of kcal) and total dietary fiber (g/d) were significantly
increased across quartile of total dietary fructose, whereas
dietary fat intakes (% of kcal) were significantly decreased
in both sexes. Mean intake of total dietary fructose in the
4th quartile was 2.8 and 3.7 times higher as compared to
the first quartile in men and women, respectively. The
means of metabolic syndrome features across quartile of
fructose intakes are provided in Figure 1. After adjustment
for age, energy intake, physical activity and smoking status,
the mean of waist circumference across quartiles of fruc-
tose intakes were significantly increased (P trend = 0.03
and 0.007, in men and women, respectively). Also, dietary
fructose intakes in men were positively associated with
systolic (P trend = 0.02) and diastolic blood pressure
(P trend = 0.013); in women, this association was observed
only for systolic blood pressure (P trend = 0.04). There
were no significant differences in serum fasting glucose,
triglycerides and HDL-C across dietary fructose categories
in men and women. The association between total dietary
fructose and MetS components is presented in Table 3.
Total dietary fructose independently correlated with waist
circumference, triglycerides, fasting blood gluocse, systolic
and diastolic blood pressure, in both men and women.
Compared with those in the lowest quartile of fructose
intakes, men and women in the highest quartile, respec-
tively, had 33% (95% CI, 1.15-1.47) and 20% (95% CI,
1.09-1.27) higher risk of the metabolic syndrome, after
adjustment for potential confounding variables (Figure 2).
Also, men and women in the highest quartile of fructose
intakes, respectively, had 39 and 20% higher risk for large
waist circumference, 11 and 9% higher risk for hyperten-
sion, and both a 9% higher risk of impaired fasting glucose.
Discussion
In this study, the higher intake of dietary fructose was
associated with the higher risk of MetS in adults, indepen-
dent of confounding variables. It should be noted that, in
our study the association between dietary fructose and
metabolic syndrome and its components was observed
only in the third and fourth quartiles of fructose intakes,
approximately over 8 and 12% of energy intake (> 50 g/d);
while dietary intake of fructose from natural sources
including fruits and vegetables, even in the fourth quartile
of fructose intakes was only 5% of energy, approximately
30 g/d. Thus, the increased risk of metabolic syndrome
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and its components may be attributed to increase fructose
intake from industrialized foods.
To our knowledge, this is the first study to directly
relate dietary fructose intake with the MetS, based on a
large population, cross-sectional setting. Johnson and
colleagues, in a recent review of animal studies and
human clinical trials, proposed that excessive fructose
intake, > 50 g/d may be one of the main etiologies of
Table 1 Characteristics of adult participants across quartiles of total dietary intake of fructose: Tehran Lipid and
Glucose Study1
Men (n = 1141) Women (n = 1396)
Q1 Q2 Q3 Q4 P 1 Q1 Q2 Q3 Q4 p
Dietary fructose range
(g/1000 kcal/d)
≤ 13.3 13.3-17.5 17.6-23.7 > 23.7 ≤ 10.3 10.4-15.2 15.3-20.8 > 20.8
Dietary fructose median
(g/1000 kcal/d)
11.1 15.4 19.7 28.1 7.2 12.6 17.9 25.9
Participants (n) 285 284 285 287 338 359 349 350
Age (y) 38 ± 12 2 39 ± 13 41 ± 13 43 ± 13 < 0.01 37 ± 12 37 ± 12 39 ± 13 41 ± 13 < 0.01
Physical activity (MET-h/wk) 40.5 ± 69.2 2 43.4 ± 74.2 45.3 ± 72.8 36.8 ± 62.4 NS 29.9 ± 37.9 32.2 ± 41.5 32.3 ± 55.5 32 ± 37.9 NS
Body mass index (kg/m2) 26.1 ± 0.2 3 26.3 ± 0.2 26.9 ± 0.2 27.3 ± 0.2 < 0.01 26.2 ± 0.2 26.8 ± 0.2 27.7 ± 0.2 27.8 ± 0.2 < 0.05
Waist/hip ratio 0.94 ± 0.07 3 0.94 ± 0.06 0.95 ± 0.06 0.96 ± 0.05 < 0.01 0.81 ± 0.08 0.82 ± 0.09 0.82 ± 0.08 0.84 ± 0.09 < 0.05
Total cholesterol (mmol/l) 4.83 ± 0.06 3 4.71 ± 0.06 4.78 ± 0.06 4.81 ± 0.06 NS 4.71 ± 0.05 4.73 ± 0.05 4.81 ± 0.05 4.88 ± 0.05 < 0.05
LDL-cholesterol (mmol/l) 3.05 ± 0.05 3 2.92 ± 0.05 2.95 ± 0.05 2.99 ± 0.05 NS 2.87 ± 0.04 2.89 ± 0.04 2.97 ± 0.04 2.84 ± 0.04 NS
Current smoker (%) 24.6 25 23.5 23.7 NS 3.0 2.2 2.9 3.4 NS
Abdominal obesity (%) 48.4 47.2 52.3 58.5 < 0.05 18.6 25.3 27.8 27.4 < 0.01
Impaired fasting glucose (%) 12.6 15.1 15.4 18.1 NS 10.1 13.9 15.8 14.0 NS
Hypertriglyceridemia (%) 44.6 41.2 44.9 46.3 NS 27.5 25.6 28.9 34.6 < 0.05
Low HDL-cholesterol (%) 58.6 63.3 57.2 64.8 NS 69.2 69.6 69.1 69.7 NS
Hypertension (%) 21.1 23.6 30.2 32.1 < 0.01 12.1 17.3 14.6 19.1 NS
Metabolic syndrome (%) 31.9 34.9 37.2 44.3 < 0.01 16.3 20.9 21.8 27.1 < 0.01
1P values comparing the characteristics of participants across quartiles of fructose intake using analysis of variance (for age and physical activity), general linear
model (for body mass index, waist/hip ratio, total and LDL-cholesterol), and Chi-square test for categorized variables.
2 Values are mean ± SD
3 Values are age-adjusted mean ± SEM
Table 2 Dietary intakes of adult participants by quartiles of total fructose intake: Tehran Lipid and Glucose Study
Males (n = 1141) Females (n = 1396)
Q1 Q2 Q3 Q4 P2 Q1 Q2 Q3 Q4 p
Energy intake (kcal/d) 2357 ± 411 2538 ± 41 2444 ± 41 2375 ± 41 < 0.05 2191 ± 35 2241 ± 34 2237 ± 34 2223 ± 34 NS
Carbohydrate (% of
energy)
56.7 ± 0.4 58.1 ± 0.4 58.8 ± 0.4 62.4 ± 0.4 < 0.05 53.4 ± 0.3 54.9 ± 0.3 56.9 ± 0.3 60.6 ± 0.3 < 0.05
Protein (% of energy) 13.6 ± 0.1 13.6 ± 0.1 13.9 ± 0.1 13.8 ± 0.1 NS 13.2 ± 0.1 13.8 ± 0.1 13.7 ± 0.1 13.7 ± 0.1 NS
Fat (% of energy) 31.1 ± 0.4 30 ± 0.4 29.9 ± 0.4 27.4 ± 0.4 < 0.001 34.9 ± 0.4 33.6 ± 0.4 32.3 ± 0.4 29.7 ± 0.4 < 0.001
Simple carbohydrate3
(% of energy)
18.9 ± 0.3 21.4 ± 0.3 24.1 ± 0.3 28.6 ± 0.3 < 0.001 18.5 ± 0.2 21.5 ± 0.2 23.7 ± 0.2 28.7 ± 0.2 < 0.001
Fiber (g/1000 kcal/d) 14.5 ± 0.4 17.3 ± 0.4 17.4 ± 0.4 18.2 ± 0.4 < 0.001 14.7 ± 0.3 15.5 ± 0.3 17.3 ± 0.3 18.6 ± 0.3 < 0.001
Natural fructose4 (%
of energy)
1.7 ± 0.04 2.6 ± 0.04 3.4 ± 0.04 5.2 ± 0.04 < 0.001 1.7 ± 0.03 2.6 ± 0.03 3.6 ± 0.03 5.4 ± 0.03 < 0.001
Added fructose5 (% of
energy)
2.5 ± 0.05 3.6 ± 0.05 4.6 ± 0.05 7.0 ± 0.05 < 0.001 1.2 ± 0.05 2.3 ± 0.05 3.6 ± 0.05 5.9 ± 0.03 < 0.001
Total dietary fructose
(% of energy) 4.3 ± 0.09 6.2 ± 0.09 8.0 ± 0.09 12.2 ± 0.09 < 0.001 2.9 ± 0.09 5.0 ± 0.09 7.2 ± 0.09 11.3 ± 0.09 < 0.001
(% of carbohydrate) 7.7 ± 0.15 10.7 ± 0.15 13.8 ± 0.15 19.6 ± 0.15 < 0.001 5.6 ± 0.14 9.3 ± 0.14 12.8 ± 0.14 18.7 ± 0.14 < 0.001
(g/d) 26.4 ± 0.7 37 ± 0.7 48.7 ± 0.7 73.6 ± 0.7 < 0.001 17.0 ± 0.6 28.2 ± 0.6 40.4 ± 0.6 63.3 ± 0.6 < 0.001
1 Data are age-adjusted mean ± SEM
2 P values comparing dietary intake of participants across quartiles of fructose intake using linear regression model.
3 Dietary Simple carbohydrates includes sucrose, maltose, galactose, glucose, fructose, maltose.
4 Natural fructose in fructose-containing food such as fruits, vegetables, honey, etc.
5 Fructose content of industrialized foods and beverages containing beet or cane sugar/molasses, corn sweeteners and invert syrup
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the metabolic syndrome [27]. In the current study, mean
intake of total fructose in men and women, was ≈ 8%
and ≈ 7% of average energy intake. Dietary fructose
from fruit, vegetable and other natural sources, was
approximately, 40 and 60% of total fructose in men and
women, respectively, while the rest was from beet and
cane sugars, soft drink, fruit drink, cookies, candies,
jams and bakery products. A recent report from the
third National Health Examination Survey (NHANES)
demonstrated that over 10% of energy intakes in US
adults were from fructose [28].
In this study, dietary fructose intakes > 12% from
energy were related to higher chances of having abdom-
inal obesity, and increasing fructose intakes were asso-
ciated with an increase in body mass index. Findings in
line with the results of studies in rats indicating that high
fructose diet increased lipogenesis, fat storage, and leptin
resistance [29-31]. Administration of 25% fructose diet in
overweight and obese subjects for 10 weeks increased
intra-abdominal fat storage [7]. Compared with other
carbohydrates, mechanisms by which fructose may cause
weight gain could be that, fructose increases hunger rat-
ing and energy intake, does not stimulate insulin and
postprandial leptin levels and inhibits secretion of orexi-
genic hormone ghrelin, as satiety signals to the brain
[32]. Fructose also up regulates de novo lipogenesis in
human [7]. The results from epidemiological studies are
inconsistent; in a prospective study, consumption of ≥ 1
soft drink per day was associated with increased risk of
developing obesity and waist circumference [33]. In













































































































































Q1 Q2 Q3 Q4
P = 0.007 
P = 0.03 
Q1 Q2 Q3 Q4
P = 0.16 
P = 0.34 
Q1 Q2 Q3 Q4
P = 0.09
P = 0.65
Q1 Q2 Q3 Q4
P = 0.99 
P = 0.18 
Q1 Q2 Q3 Q4
P = 0.04 
P = 0.02 
Q1 Q2 Q3 Q4
P = 0.013 
P = 0.15 
Figure 1 The means of metabolic syndrome components across quartiles of fructose intakes. General linear models were used with
adjustment for age, physical activity, body mass index, smoking status, energy intake, dietary intake of carbohydrate, fat, simple carbohydrate
(except fructose),and fiber, and additionally adjusted for current estrogen use and menopausal status in women. Total dietary fructose intakes (g/
1000 kcal/d) in 1th, 2 th, 3th and 4th quartiles were ≤13.3, 13.4-17.5, 17.6-23.7, and > 23.7 in men, and ≤ 10.3, 10.4-15.2, 15.3-20.8, and > 20.8 in
women. Dietary fructose intake positively associated with waist circumference and systolic blood pressure in both sexes and diastolic blood
pressure in men.
Table 3 Multivariate association between total dietary fructose intake and metabolic syndrome components: Tehran
Lipid and Glucose Study
WC TG FBS HDL-C SBP DBP
Men 0.158 (0.001) 0.076 (0.08) 0.115 (0.007) -0.066 (0.12) 0.103 (0.016) 0.167 (0.001)
Women 0.155 (0.001) 0.130 (0.001) 0.135 (0.001) -0.012 (0.76) 0.164 (0.001) 0.115 (0.006)
Values are standardized coefficient b (P value) were determined using the linear regression model with adjustment for age, physical activity, body mass index
(except for waist circumference and metabolic syndrome), smoking status, energy intake, dietary intake of carbohydrate, fat, simple sugar (except fructose), and
fiber. WC; Waist circumference, TG; Triglycerides, FBS; Fasting blood glucose, HDL-C; High density lipoprotein, SBP; Systolic blood pressure, DBP; Diastolic blood
pressure.
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In this study, participants with the highest intakes of
fructose had higher risk of impaired fasting glucose.
Although fructose does not stimulate insulin secretion,
it induced impaired fasting glucose by insulin resistance
in the liver and adipose tissue [35,36]. In humans, high
doses of fructose decreased insulin sensitivity and glu-
cose tolerance in older, overweight and obese subjects,






























































































    Q1        Q2        Q3       Q4       Q1       Q2       Q3       Q4 
Abdominal obesity 
Men Women 
    Q1        Q2        Q3       Q4       Q1       Q2       Q3       Q4 
P trend = 0.20 P trend = 0.004 
Hyperglycemia 
Impaired fasting glucose  
Men Women 
P trend = 0.20 P trend = 0.35 
    Q1        Q2        Q3       Q4       Q1       Q2       Q3       Q4 
    Q1        Q2        Q3       Q4       Q1       Q2       Q3       Q4 
P trend = 0.77 P trend = 0.25 
    Q1        Q2        Q3       Q4       Q1       Q2       Q3       Q4 
Hypertension 
Men Women 
P trend = 0.003 P trend = 0.049
    Q1        Q2        Q3       Q4       Q1       Q2       Q3       Q4 
Metabolic syndrome 
Men Women 
P trend = 0.001 P trend = 0.004
Low HDL-cholesterol 
Men Men Women Women 
P trend = 0.003 
Figure 2 Multivariate odds ratio and 95% confidence interval for the metabolic syndrome and its components across quartiles of
fructose intake. Logistic regression models were used with adjustment for age, physical activity, body mass index, smoking status, energy
intake, dietary intake of carbohydrate, fat, simple carbohydrate (except fructose), fiber, and additionally adjusted for current estrogen use and
menopausal status in women. Total dietary fructose intakes (g/1000 kcal/d) in 1th, 2 th, 3th and 4th quartiles were ≤ 13.3, 13.4-17.5, 17.6-23.7, and
> 23.7 in men, and ≤ 10.3, 10.4-15.2, 15.3-20.8, and > 20.8 in women. To assess the overall trends of odds ratios across increasing quartiles of
total fructose intake, the median fructose intake of each quartile was used as a continuous variable in logistic regression models.
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men; however fructose caused a 5.5% increase in fasting
glucose concentration in these subjects [7,37]. A large
cross-sectional study showed that the highest quintile of
fructose intake had 13.9% higher C-peptide levels, as a
risk factor for insulin resistance [38].
In the present study, fructose intakes > 72 and 63 g/d
in men and women were associated with 11 and 9%
increased risk of hypertension, respectively. In one
study, administration of 200 g/d fructose in healthy
adults significantly increased systolic and diastolic blood
pressure [39]. In the Framingham Heart Study, con-
sumption of soft drinks increased risk of hypertension
[33]. Furthermore, recent data from a cross-sectional
study demonstrated that high fructose intake in the
form of added sugar was associated with higher blood
pressure levels in adults [40]. Some studies proposed
that hypertension-induced effects of fructose may be
related to the ability of fructose to increase serum uric
acid and enhance reabsorption of salt and water in the
small intestine and kidney [41,42]. However in a recent
cross-sectional study, no association was found between
dietary fructose and risk of hyperuricemia in adults [21].
Also, blood pressure did not change with the high con-
sumption of fructose over the course of the 10 week
intervention period [7].
The current study showed that there were no signifi-
cant associations between fructose intake and fasting
serum triglycerides, and HDL-cholesterol. Excessive fruc-
tose intake for 2 weeks in healthy subjects resulted in
hypertriglyceridemia and decreased HDL-cholesterol
levels (39). Stanhope et al showed that administration of a
diet with 25% fructose for 10 weeks did not change fast-
ing TG concentrations, but increased postprandial de
novo lipogenesis and TG concentrations, fasting and
postprandial apo B and LDL-C concentrations in over-
weight and obese subjects [7]. However results from a
recent meta-analysis, suggested that dietary fructose
intakes less than 50 g/d had no adverse effect on fasting
and postprandial triglycerides [43]. Although, in an
observational study of overweight children, no associa-
tion was observed between fructose consumption and
HDL, LDL, total cholesterol and triglyceride concentra-
tions, fructose intake was a significant predictor of LDL
particle size as an atherogenic risk factor [44]. More
observational studies need to be conducted on the asso-
ciation between usual intakes of fructose and lipid pro-
files among adults.
One limitation of this study is the use of an FFQ for
collecting dietary data. Also total fructose intake was
estimated approximately, because of a lack of fructose
content data for many food items. In addition, this is a
cross sectional study which limits ability to determine
causality between dietary fructose intake, MetS and its
components.
In conclusion, in this study, higher dietary fructose
intake was significantly associated with the increased
risk of metabolic syndrome and some of its risk factors
including abdominal obesity, hypertension and impaired
fasting glucose in adults, even after adjustment for
demographic, anthropometric and dietary intakes.
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